Singapore: Takeda and Affymax, announced that Takeda Pharmaceuticals America (TPA) has entered into a supply agreement ...
Singapore: A phase III memorandum of understanding (MoU) was signed between Thailand's BIOTEC and Japan's National Insti...
Singapore: Japanese pharma major Takeda Pharma has announced that it has received approval of Adcetris (brentuximab vedo...
Singapore: Verastem, a biopharmaceutical company focused on discovering and developing drugs to treat breast and other c...
Singapore: Therapeutically focused global clinical research organization, INC Research LLC has announced the establishme...
Singapore: Sosei Group's Japanese subsidiary initiated a phase III trial for SO-1105 for the treatment of oropharyngeal...
Singapore: Researchers from Japan's RIKEN Center for Developmental biology have developed a new sugar and water-based so...
Singapore: US-based Cytokinetics and Japan-based Astellas Pharma entered in a two-year collaboration focused on the R&am...
Singapore: Astellas Pharma and XenoPort have launched Regnite (gabapentin enacarbil) extended-release tablets. Regnite i...
Singapore: The Scripps Research Institute (TSRI) and Takeda Pharmaceutical plan to expand their recent research collabo...
Singapore: Japanese company I'rom Holdings will acquire an 18.8 percent stake in IDT Australia. I'rom is listed on the T...
Singapore: The Japanese unit of AstraZeneca (AZ), has been acquitted, in a case that had held the firm responsible for t...
Asia needs a solution, that goes beyond traditional structure, models and pathways, to meet the essential vaccine supply...
Singapore: Japan's Daiichi Sankyo and Ranbaxy Laboratories have plans to integrate their business operations in Thailand...
Singapore: A new power-free microfluidic chip developed by researchers at the RIKEN Advanced Science Institute, Japan, ...
Singapore: Japan based Hoya Corporation has appointed Mr Augustine Yee as its executive officer, chief legal officer and...
Singapore: Takeda Pharmaceuticals' Deerfield campus has been listed among Chicago's top 100 workplaces by the Chicago T...
Singapore: Japan-based Eisai is going to launch its new carbonated supplement drink named 'Chocola BB Sparkling + Fiber'...
Singapore: Eisai, which has its headquarters in Tokyo, has submitted a marketing authorization application to Japan's Mi...
Singapore: Keryx Biopharmaceuticals announced that its Japanese partner, Japan Tobacco (JT), has filed a New Drug Appli...
Singapore: The US FDA has accepted Astellas Pharma's US subsidiary filing of a supplemental New Drug Application (sNDA) ...
Singapore: The European Medicines Agency (EMA) has accepted the marketing authorization application for review of an aty...
New Delhi: Ranbaxy issued an advisory claiming that all their products in the Indian and global markets are safe and eff...
Singapore: Global biopharmaceutical company Amgen plans to acquire all the outstanding shares of Onyx Pharmaceuticals fo...
Singapore: The TRILOGY ACS study, a phase III trial comparing prasugrel plus aspirin to clopidogrel plus aspirin in pati...
